Lithuanian biotech trailblazer eyes 3D printouts of cells and organs
The €200 million Celltechna project that aims to produce 3D printouts of human cells and entire body organs. One of the Celltechna plants will employ gene engineering whilst manufacturing new medicine from ‘protein-folding’-based technologies involving microbe cells. The other Celltechna facility will produce medicine from mammalian cells and the third will devote itself to cell therapy technologies.
See more: www.nbforum.com